Compare GPMT & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GPMT | BHST |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 87 |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.9M | 104.2M |
| IPO Year | N/A | N/A |
| Metric | GPMT | BHST |
|---|---|---|
| Price | $1.40 | $4.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $3.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 140.1K | 15.9K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | ★ 13.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $422.75 | $116.40 |
| Revenue Next Year | $34.54 | $55.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.41 | $4.10 |
| 52 Week High | $3.12 | $12.80 |
| Indicator | GPMT | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 23.64 | 44.49 |
| Support Level | N/A | $4.19 |
| Resistance Level | $1.83 | $4.96 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 4.35 | 24.64 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.